ABSTRACT
Trade name: Lucentis (Genentech) Indications: Wet, age-related macular degeneration Category: Recombinant humanized monoclonal antibody Half-life: 9 days Clinically important, potentially hazardous interactions with: N/A
- Journals
- Corporate
- Help & Contact
Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG© 2024 Informa UK Limited